
3MGBP
Type
Common Stock
Exchange
LSE
Currency Code
GBX
Currency Name
Pence sterling
Country Name
UK
Country ISO
GB
ISIN
GB00BLH13C52
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.01
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.01
Wall Street Target Price
6.00
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
49,775
Gross Profit TTM
49,775
EBITDA
-1,763,130
Profit Margin
0.00%
Return On Assets TTM
-37.13%
Return On Equity TTM
-57.69%
Revenue Per Share TTM
0
Qtly Revenue Growth YOY
418.50%
Diluted Eps TTM
-0.01
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
45.5157
Price Book MRQ
0.6564
Enterprise Value Revenue
35
Enterprise Value EBITDA
-5
66.20
4.25%236.28
1.25%113.60
0.53%115.20
-3.92%87.50
-2.91%1.41
-2.84%2474.00
-2.60%550.00
-1.79%1.96
-0.93%1747.25
-0.51%